NASHVILLE, Tenn. -- (Business Wire)
AmSurg Corp. (“AmSurg”) (NASDAQ: AMSG) today announced that it has
priced its underwritten public offering of 5,500,000 shares of its
common stock at a price of $80.00 per share. The net proceeds from the
offering will be approximately $422 million, after estimated issuance
discounts and commissions. AmSurg intends to use the net proceeds from
the offering to repay outstanding indebtedness under its revolving
credit facility borrowed to fund its recent acquisitions, to fund a
portion of the approximately $500 million of acquisition opportunities
in its pipeline that are under letter of intent and targeted to close
between now and the end of the first quarter of 2016 and for other
general corporate purposes. In addition, AmSurg has granted the
underwriters a 30-day option to purchase up to an additional 825,000
shares of its common stock.
SunTrust Robinson Humphrey and J.P. Morgan are acting as lead joint
book-running managers for the offering. BMO Capital Markets, Jefferies
and Guggenheim Securities are acting as joint book-running managers, and
Baird, Avondale Partners, KeyBanc Capital Markets, Piper Jaffray and
Raymond James are acting as co-managers. The offering is being made
pursuant to an effective shelf registration statement filed with the
Securities and Exchange Commission (“SEC”). The offering will be made
only by means of a prospectus supplement and the accompanying base
prospectus, copies of which may be obtained by contacting (i) SunTrust
Robinson Humphrey, 3333 Peachtree Road NE, 9th Floor, Atlanta, GA 30326,
Attention: Prospectus Department; email: strh.prospectus@suntrust.com;
telephone: 404-926-5744; or fax: 404-926-5464 or (ii) J.P. Morgan
Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island
Avenue, Edgewater, NY 11717, or telephone: 866-803-9204. These documents
will also be filed with the SEC and will be available at the SEC’s
website at http://www.sec.gov.
The press release shall not constitute an offer to sell or a
solicitation of an offer to buy the securities described herein, nor
shall there be any sale of these securities in any state or other
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities
laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the federal securities laws, including statements related to
the expected use of the net proceeds therefrom, which are based on
current expectations, forecasts and assumptions that involve risks and
uncertainties that could cause actual outcomes and results to differ
materially. Forward-looking statements relate to expectations, beliefs,
projections, future plans and strategies, anticipated events or trends
and similar expressions concerning matters that are not historical
facts. In some cases, you can identify forward-looking statements by the
use of forward-looking terminology such as “may,” “will,” “should,”
“expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,”
or “predicts,” or the negative of these words or phrases or similar
words or phrases, which are predictions of or indicate future events or
trends and which do not relate solely to historical matters. While
forward-looking statements reflect AmSurg’s good faith beliefs,
assumptions and expectations, they are not guarantees of future
performance. Furthermore, AmSurg disclaims any obligation to publicly
update or revise any forward-looking statement to reflect changes in
underlying assumptions or factors, of new information, data or methods,
future events or other changes. These forward-looking statements are
based on a variety of assumptions that may not be realized and that are
subject to significant risks and uncertainties, including that the
acquisitions may not be consummated and that the anticipated financial
and strategic benefits of the acquisitions may not be realized, as well
as risks and uncertainties referenced from time to time in the Company’s
filings with the SEC.
About AmSurg Corp.
AmSurg’s Ambulatory Services Division acquires, develops and operates
ambulatory surgery centers in partnership with physicians throughout the
U.S. AmSurg’s Physician Services Division, Sheridan, provides outsourced
physician services in multiple specialties to hospitals, ASCs and other
healthcare facilities throughout the U.S., primarily in the areas of
anesthesiology, children’s services, emergency medicine and radiology.
Through these businesses as of September 30, 2015, AmSurg owned and
operated 253 ASCs and one surgical hospital in 34 states and provided
physician services to more than 360 healthcare facilities in 27 states.
AmSurg has partnerships with, or employs, over 5,000 physicians in 38
states and the District of Columbia.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151201006871/en/
Contacts:
AmSurg Corp.
Claire M. Gulmi, 615-665-1283
Executive Vice
President and Chief Financial Officer
Source: AmSurg Corp.
© 2024 Canjex Publishing Ltd. All rights reserved.